Artykuły w czasopismach na temat „3CLpro”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „3CLpro”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Ziebuhr, John, Sonja Bayer, Jeff A. Cowley i Alexander E. Gorbalenya. "The 3C-Like Proteinase of an Invertebrate Nidovirus Links Coronavirus and Potyvirus Homologs". Journal of Virology 77, nr 2 (15.01.2003): 1415–26. http://dx.doi.org/10.1128/jvi.77.2.1415-1426.2003.
Pełny tekst źródłaTsu, Brian V., Rimjhim Agarwal, Nandan S. Gokhale, Jessie Kulsuptrakul, Andrew P. Ryan, Elizabeth J. Fay, Lennice K. Castro i in. "Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome". PLOS Biology 21, nr 6 (8.06.2023): e3002144. http://dx.doi.org/10.1371/journal.pbio.3002144.
Pełny tekst źródłaRawson, Jonathan M. O., Alice Duchon, Olga A. Nikolaitchik, Vinay K. Pathak i Wei-Shau Hu. "Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CLpro Inhibitors". Viruses 13, nr 2 (24.01.2021): 173. http://dx.doi.org/10.3390/v13020173.
Pełny tekst źródłaZhang, Jingjing, Yingpei Jiang, Chunxiu Wu, Dan Zhou, Jufang Gong, Tiejun Zhao i Zhigang Jin. "Development of FRET and Stress Granule Dual-Based System to Screen for Viral 3C Protease Inhibitors". Molecules 28, nr 7 (28.03.2023): 3020. http://dx.doi.org/10.3390/molecules28073020.
Pełny tekst źródłaSanachai, Kamonpan, Tuanjai Somboon, Patcharin Wilasluck, Peerapon Deetanya, Peter Wolschann, Thierry Langer, Vannajan Sanghiran Lee, Kittikhun Wangkanont, Thanyada Rungrotmongkol i Supot Hannongbua. "Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening". PLOS ONE 17, nr 6 (30.06.2022): e0269563. http://dx.doi.org/10.1371/journal.pone.0269563.
Pełny tekst źródłaGlab-ampai, Kittirat, Kanasap Kaewchim, Thanatsaran Saenlom, Watayagorn Thepsawat, Kodchakorn Mahasongkram, Nitat Sookrung, Wanpen Chaicumpa i Monrat Chulanetra. "Human Superantibodies to 3CLpro Inhibit Replication of SARS-CoV-2 across Variants". International Journal of Molecular Sciences 23, nr 12 (13.06.2022): 6587. http://dx.doi.org/10.3390/ijms23126587.
Pełny tekst źródłaYe, Gang, Xiaowei Wang, Xiaohan Tong, Yuejun Shi, Zhen F. Fu i Guiqing Peng. "Structural Basis for Inhibiting Porcine Epidemic Diarrhea Virus Replication with the 3C-Like Protease Inhibitor GC376". Viruses 12, nr 2 (21.02.2020): 240. http://dx.doi.org/10.3390/v12020240.
Pełny tekst źródłaChen, Chia-Nan, Coney P. C. Lin, Kuo-Kuei Huang, Wei-Cheng Chen, Hsin-Pang Hsieh, Po-Huang Liang i John T. A. Hsu. "Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3)". Evidence-Based Complementary and Alternative Medicine 2, nr 2 (2005): 209–15. http://dx.doi.org/10.1093/ecam/neh081.
Pełny tekst źródłaRana, Shiwani, Prateek Kumar, Anchal Sharma, Sanjay Sharma, Rajanish Giri i Kalyan S. Ghosh. "Identification of Naturally Occurring Antiviral Molecules for SARS-CoV-2 Mitigation". Open COVID Journal 1, nr 1 (10.06.2021): 38–46. http://dx.doi.org/10.2174/2666958702101010038.
Pełny tekst źródłaWu, Jing, Bo Feng, Li-Xin Gao, Chun Zhang, Jia Li, Da-Jun Xiang, Yi Zang i Wen-Long Wang. "Synthesis and Biochemical Evaluation of 8H-Indeno[1,2-d]thiazole Derivatives as Novel SARS-CoV-2 3CL Protease Inhibitors". Molecules 27, nr 10 (23.05.2022): 3359. http://dx.doi.org/10.3390/molecules27103359.
Pełny tekst źródłaKim, Yunjeong, Vinay Shivanna, Sanjeev Narayanan, Allan M. Prior, Sahani Weerasekara, Duy H. Hua, Anushka C. Galasiti Kankanamalage, William C. Groutas i Kyeong-Ok Chang. "Broad-Spectrum Inhibitors against 3C-Like Proteases of Feline Coronaviruses and Feline Caliciviruses". Journal of Virology 89, nr 9 (18.02.2015): 4942–50. http://dx.doi.org/10.1128/jvi.03688-14.
Pełny tekst źródłaNaumovich, Vladislav, Maria Grishina i Vladimir Potemkin. "Establishment of models for reliability evaluation of 3CLpro ligand-receptor complexes with different binding sites". Future Medicinal Chemistry 14, nr 7 (kwiecień 2022): 501–10. http://dx.doi.org/10.4155/fmc-2021-0271.
Pełny tekst źródłaZhang, Yue, Huijie Chen, Mengmeng Zou, Rick Oerlemans, Changhao Shao, Yudong Ren, Ruili Zhang, Xiaodan Huang, Guangxing Li i Yingying Cong. "Hypericin Inhibit Alpha-Coronavirus Replication by Targeting 3CL Protease". Viruses 13, nr 9 (14.09.2021): 1825. http://dx.doi.org/10.3390/v13091825.
Pełny tekst źródłaAhmad, Bilal, Maria Batool, Qurat ul Ain, Moon Suk Kim i Sangdun Choi. "Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations". International Journal of Molecular Sciences 22, nr 17 (24.08.2021): 9124. http://dx.doi.org/10.3390/ijms22179124.
Pełny tekst źródłaLu, Xiao Tao, Amy C. Sims i Mark R. Denison. "Mouse Hepatitis Virus 3C-Like Protease Cleaves a 22-Kilodalton Protein from the Open Reading Frame 1a Polyprotein in Virus-Infected Cells and In Vitro". Journal of Virology 72, nr 3 (1.03.1998): 2265–71. http://dx.doi.org/10.1128/jvi.72.3.2265-2271.1998.
Pełny tekst źródłaIbrahim, Mahmoud A. A., Alaa H. M. Abdelrahman, Dina E. M. Mohamed, Khlood A. A. Abdeljawaad, Mohamed Ahmed Naeem, Gamal A. Gabr, Ahmed M. Shawky i in. "Chetomin, a SARS-CoV-2 3C-like Protease (3CLpro) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis". Viruses 15, nr 1 (15.01.2023): 250. http://dx.doi.org/10.3390/v15010250.
Pełny tekst źródłaFakih, Taufik Muhammad, i Dwi Syah Fitra Ramadhan. "Prediction of SARS-CoV-2 3C-like protease (3CLpro) crystal structure to provide COVID-19 inhibitor design through computational studies". Biogenesis: Jurnal Ilmiah Biologi 9, nr 2 (30.12.2021): 213–19. http://dx.doi.org/10.24252/bio.v9i2.24520.
Pełny tekst źródłaMa, Ling, Yongli Xie, Mei Zhu, Dongrong Yi, Jianyuan Zhao, Saisai Guo, Yongxin Zhang i in. "Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CLpro". International Journal of Molecular Sciences 23, nr 24 (16.12.2022): 16011. http://dx.doi.org/10.3390/ijms232416011.
Pełny tekst źródłaValipour, Mehdi, Silvia Di Giacomo, Antonella Di Sotto i Hamid Irannejad. "Discovery of Chalcone-Based Hybrid Structures as High Affinity and Site-Specific Inhibitors against SARS-CoV-2: A Comprehensive Structural Analysis Based on Various Host-Based and Viral Targets". International Journal of Molecular Sciences 24, nr 10 (15.05.2023): 8789. http://dx.doi.org/10.3390/ijms24108789.
Pełny tekst źródłaGuijarro-Real, Carla, Mariola Plazas, Adrián Rodríguez-Burruezo, Jaime Prohens i Ana Fita. "Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity". Foods 10, nr 7 (29.06.2021): 1503. http://dx.doi.org/10.3390/foods10071503.
Pełny tekst źródłaJukič, Marko, Blaž Škrlj, Gašper Tomšič, Sebastian Pleško, Črtomir Podlipnik i Urban Bren. "Prioritisation of Compounds for 3CLpro Inhibitor Development on SARS-CoV-2 Variants". Molecules 26, nr 10 (18.05.2021): 3003. http://dx.doi.org/10.3390/molecules26103003.
Pełny tekst źródłaHuynh, Thi Ngoc Thanh, Thi Thanh Thu Tran, Thi My Hanh Pham i Kha Quang Quach. "Study on the interaction mechanism of penciclovir drug on 3CLpro of SAR-COV-2 by simulation methods". Dong Thap University Journal of Science 12, nr 5 (23.06.2023): 42–47. http://dx.doi.org/10.52714/dthu.12.5.2023.1070.
Pełny tekst źródłaChen, Lili, Shuai Chen, Chunshan Gui, Jianhua Shen, Xu Shen i Hualiang Jiang. "Discovering Severe Acute Respiratory Syndrome Coronavirus 3CL Protease Inhibitors: Virtual Screening, Surface Plasmon Resonance, and Fluorescence Resonance Energy Transfer Assays". Journal of Biomolecular Screening 11, nr 8 (grudzień 2006): 915–21. http://dx.doi.org/10.1177/1087057106293295.
Pełny tekst źródłaHamill, Pamela, Derek Hudson, Richard Y. Kao, Polly Chow, Meera Raj, Hongyan Xu, Martin J. Richer i François Jean. "Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata". Biological Chemistry 387, nr 8 (1.08.2006): 1063–74. http://dx.doi.org/10.1515/bc.2006.131.
Pełny tekst źródłaJo, Seri, Hwa Young Kim, Dong Hae Shin i Mi-Sun Kim. "Dimerization Tendency of 3CLpros of Human Coronaviruses Based on the X-ray Crystal Structure of the Catalytic Domain of SARS-CoV-2 3CLpro". International Journal of Molecular Sciences 23, nr 9 (9.05.2022): 5268. http://dx.doi.org/10.3390/ijms23095268.
Pełny tekst źródłaGarland, Gavin D., Robert F. Harvey, Thomas E. Mulroney, Mie Monti, Stewart Fuller, Richard Haigh, Pehuén Pereyra Gerber, Michael R. Barer, Nicholas J. Matheson i Anne E. Willis. "Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity". Biochemical Journal 479, nr 8 (21.04.2022): 901–20. http://dx.doi.org/10.1042/bcj20220105.
Pełny tekst źródłaLi, Zhonghua, Hua Cao, Yufang Cheng, Xiaoqian Zhang, Wei Zeng, Yumei Sun, Shuhua Chen, Qigai He i Heyou Han. "Inhibition of Porcine Epidemic Diarrhea Virus Replication and Viral 3C-Like Protease by Quercetin". International Journal of Molecular Sciences 21, nr 21 (30.10.2020): 8095. http://dx.doi.org/10.3390/ijms21218095.
Pełny tekst źródłaFitriana, Adita Silvia, i Sri Royani. "Molecular Docking Study of Chalcone Derivatives as Potential Inhibitors of SARS-CoV-2 Main Protease". Indo. J. Chem. Res. 9, nr 3 (29.01.2022): 150–62. http://dx.doi.org/10.30598//ijcr.2022.9-fit.
Pełny tekst źródłaHegyi, Annette, Agnes Friebe, Alexander E. Gorbalenya i John Ziebuhr. "Mutational analysis of the active centre of coronavirus 3C-like proteases". Journal of General Virology 83, nr 3 (1.03.2002): 581–93. http://dx.doi.org/10.1099/0022-1317-83-3-581.
Pełny tekst źródłaSaquib, Quaiser, Ahmed H. Bakheit, Sarfaraz Ahmed, Sabiha M. Ansari, Abdullah M. Al-Salem i Abdulaziz A. Al-Khedhairy. "Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CLPro and PLPro) by Molecular Docking and Dynamic Simulation Studies". Molecules 29, nr 5 (25.02.2024): 998. http://dx.doi.org/10.3390/molecules29050998.
Pełny tekst źródłaKomissarov, Alexey, Maria Karaseva, Marina Roschina, Sergey Kostrov i Ilya Demidyuk. "The SARS-CoV-2 main protease doesn’t induce cell death in human cells in vitro". PLOS ONE 17, nr 5 (24.05.2022): e0266015. http://dx.doi.org/10.1371/journal.pone.0266015.
Pełny tekst źródłaZhang, Shilei, Jingfeng Wang i Genhong Cheng. "Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1". Proceedings of the National Academy of Sciences 118, nr 37 (27.08.2021): e2107108118. http://dx.doi.org/10.1073/pnas.2107108118.
Pełny tekst źródłaDuarte Filho, Luiz Antonio Miranda de Souza, Cintia Emi Yanaguibashi Leal, Pierre-Edouard Bodet, Edilson Beserra de Alencar Filho, Jackson Roberto Guedes da Silva Almeida, Manon Porta Zapata, Oussama Achour i in. "The Identification of Peptide Inhibitors of the Coronavirus 3CL Protease from a Fucus ceranoides L. Hydroalcoholic Extract Using a Ligand-Fishing Strategy". Marine Drugs 22, nr 6 (27.05.2024): 244. http://dx.doi.org/10.3390/md22060244.
Pełny tekst źródłaRajeswari, Kalepu, W. Jun Chen, A. Aashika, T. Xian Ying, C. Choon Hoong, S. Kuha i Diya Rajasekhar Chinta. "Binding Interaction Analysis of Phytoconstituents of Commiphora mukul with 3CLPro and PlPro Enzymes of SARS-CoV-2 Virus". ECS Transactions 107, nr 1 (24.04.2022): 7509–30. http://dx.doi.org/10.1149/10701.7509ecst.
Pełny tekst źródłaWang, Yaxin, Binghong Xu, Sen Ma, Hao Wang, Luqing Shang, Cheng Zhu i Sheng Ye. "Discovery of SARS-CoV-2 3CLPro Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein–Ligand Interactions". International Journal of Molecular Sciences 23, nr 4 (21.02.2022): 2392. http://dx.doi.org/10.3390/ijms23042392.
Pełny tekst źródłaOlubiyi, Olujide O., Maryam Olagunju, Monika Keutmann, Jennifer Loschwitz i Birgit Strodel. "High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2". Molecules 25, nr 14 (13.07.2020): 3193. http://dx.doi.org/10.3390/molecules25143193.
Pełny tekst źródłaYang, Cheng-Wei, Yung-Ning Yang, Po-Huang Liang, Chi-Min Chen, Wei-Liang Chen, Hwan-You Chang, Yu-Sheng Chao i Shiow-Ju Lee. "Novel Small-Molecule Inhibitors of Transmissible Gastroenteritis Virus". Antimicrobial Agents and Chemotherapy 51, nr 11 (20.08.2007): 3924–31. http://dx.doi.org/10.1128/aac.00408-07.
Pełny tekst źródłaSobhy, Remah, Asad Nawaz, Mohammad Fikry, Rokayya Sami, Eman Algarni, Nada Benajiba, Sameer H. Qari, Alaa T. Qumsani i Ibrahim Khalifa. "In-Silico Evaluation of 10 Structurally Different Glucosinolates on the Key Enzyme of SARS-CoV-2". Science of Advanced Materials 14, nr 1 (1.01.2022): 162–74. http://dx.doi.org/10.1166/sam.2022.4190.
Pełny tekst źródłaDu, Weian, Liang Zhao, Rong Wu, Boning Huang, Si Liu, Yufeng Liu, Huaiqiu Huang i Ge Shi. "Predicting drug–Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2". PLOS ONE 19, nr 5 (10.05.2024): e0299696. http://dx.doi.org/10.1371/journal.pone.0299696.
Pełny tekst źródłaHaniyya, M. Ulfah, A. Riswoko, L. Mulyawati, T. Ernawati i I. Helianti. "Production of recombinant SARS-CoV-2 3CL-protease: The key for the development of protease inhibitors screening kit in search of potential herb cure for COVID-19". IOP Conference Series: Earth and Environmental Science 976, nr 1 (1.02.2022): 012051. http://dx.doi.org/10.1088/1755-1315/976/1/012051.
Pełny tekst źródłaZiebuhr, John, i Stuart G. Siddell. "Processing of the Human Coronavirus 229E Replicase Polyproteins by the Virus-Encoded 3C-Like Proteinase: Identification of Proteolytic Products and Cleavage Sites Common to pp1a and pp1ab". Journal of Virology 73, nr 1 (1.01.1999): 177–85. http://dx.doi.org/10.1128/jvi.73.1.177-185.1999.
Pełny tekst źródłaCheng, Jin, Yixuan Hao, Qin Shi, Guanyu Hou, Yanan Wang, Yong Wang, Wen Xiao i in. "Discovery of Novel Chinese Medicine Compounds Targeting 3CL Protease by Virtual Screening and Molecular Dynamics Simulation". Molecules 28, nr 3 (17.01.2023): 937. http://dx.doi.org/10.3390/molecules28030937.
Pełny tekst źródłaRazali, Rafida, Vijay Kumar Subbiah i Cahyo Budiman. "Technical Data of Heterologous Expression and Purification of SARS-CoV-2 Proteases Using Escherichia coli System". Data 6, nr 9 (16.09.2021): 99. http://dx.doi.org/10.3390/data6090099.
Pełny tekst źródłaRizzuti, Bruno, Laura Ceballos-Laita, David Ortega-Alarcon, Ana Jimenez-Alesanco, Sonia Vega, Fedora Grande, Filomena Conforti, Olga Abian i Adrian Velazquez-Campoy. "Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds". Pharmaceuticals 14, nr 9 (1.09.2021): 892. http://dx.doi.org/10.3390/ph14090892.
Pełny tekst źródłaMorita, Takeshi, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Yutaro Yamaoka, Mitsuru Sada, Tomoko Kuniyoshi, Jinwei Yang, Hirokazu Kimura i Akihide Ryo. "All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity". Viruses 13, nr 8 (23.08.2021): 1669. http://dx.doi.org/10.3390/v13081669.
Pełny tekst źródłaAHMED, N. ZAHEER, DICKY JOHN DAVIS, NOMAN ANWAR, ASIM ALI KHAN, RAM PRATAP MEENA, ZEBA AFNAAN i MEERA DEVI. "In-Silico Evaluation of Tiryaq-E-Wabai, an Unani Formulation for its Potency against SARS-CoV-2 Spike Glycoprotein and Main Protease". Journal of Drug Delivery and Therapeutics 11, nr 4-S (15.08.2021): 86–100. http://dx.doi.org/10.22270/jddt.v11i4-s.4993.
Pełny tekst źródłaRizma, Baiq Ressa Puspita, Yek Zen Mubarok, Dian Fathita Dwi Lestari i Agus Dwi Ananto. "Molecular Study of Antiviral Compound of Indonesian Herbal Medicine as 3CLpro and PLpro Inhibitor in SARS-COV-2". Acta Chimica Asiana 4, nr 2 (29.10.2021): 127–34. http://dx.doi.org/10.29303/aca.v4i2.74.
Pełny tekst źródłaHerlah, Barbara, Andrej Hoivik, Luka Jamšek, Katja Valjavec, Norio Yamamoto, Tyuji Hoshino, Krištof Kranjc i Andrej Perdih. "Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CLpro Main Protease". Pharmaceuticals 15, nr 5 (27.04.2022): 539. http://dx.doi.org/10.3390/ph15050539.
Pełny tekst źródłaFagnani, Lorenza, Lisaurora Nazzicone, Pierangelo Bellio, Nicola Franceschini, Donatella Tondi, Andrea Verri, Sabrina Petricca i in. "Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators". Pharmaceuticals 15, nr 6 (4.06.2022): 714. http://dx.doi.org/10.3390/ph15060714.
Pełny tekst źródłaMohammad, Firdous Sayeed, Mohsina F. Patwekar i Faheem I. Patwekar. "Are Plant-derived Flavonoids the Emerging Anti-coronavirus Agents?" INNOSC Theranostics and Pharmacological Sciences 4, nr 2 (29.04.2022): 11–16. http://dx.doi.org/10.36922/itps.v4i2.42.
Pełny tekst źródła